CHAMPIONS ONCOLOGY, INC. (CSBR) Share buybacks
- Total buybacks · last 12 months (USD): Value $0.00; Formula and calculation Trailing-year cash paid for share repurchases. Period ending 2025-04-30..
- Buyback yield · 12 months: Value (m); Formula and calculation Cash paid for share repurchases / current market cap. Period ending 2025-04-30..
Share buybacks
Overview →Financial period ending 2025-04-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total buybacks · last 12 months (USD) | $0.00 | Trailing-year cash paid for share repurchases. Period ending 2025-04-30. |
| Buyback yield · 12 months | (m) | Cash paid for share repurchases / current market cap. Period ending 2025-04-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Buybacks · 12 months | 0.00 USD | Payments for Repurchase of Common Stock |
| Market cap | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total buybacks | Market cap (USD) | Buyback yield |
|---|---|---|---|
| 2025-04-30 | $0.00 | (m) | (m) |
| 2025-01-31 | $0.00 | (m) | (m) |
| 2024-10-31 | $0.00 | (m) | (m) |
| 2024-07-31 | $32.00K | (m) | (m) |
| 2024-04-30 | $634.00K | (m) | (m) |
| 2024-01-31 | $708.00K | (m) | (m) |
| 2023-10-31 | $708.00K | (m) | (m) |
| 2023-07-31 | $676.00K | (m) | (m) |
| 2023-04-30 | $74.00K | (m) | (m) |
| 2023-01-31 | (m) | (m) | (m) |
| 2022-10-31 | (m) | (m) | (m) |
| 2022-07-31 | (m) | (m) | (m) |
| 2022-04-30 | $0.00 | (m) | (m) |
| 2012-04-30 | $0.00 | (m) | (m) |
| 2012-01-31 | (m) | (m) | (m) |
| 2011-10-31 | (m) | (m) | (m) |
| 2011-07-31 | (m) | (m) | (m) |
| 2011-04-30 | $1.03M | (m) | (m) |
| 2011-01-31 | (m) | (m) | (m) |
| 2010-10-31 | (m) | (m) | (m) |
| 2010-07-31 | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |